VERU ($VERU) posted quarterly earnings results on Thursday, May 8th. The company reported earnings of -$0.05 per share, beating estimates of -$0.06 by $0.01. The company also reported revenue of $0, missing estimates of $591,600 by $-591,600.
You can see Quiver Quantitative's $VERU stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
VERU Insider Trading Activity
VERU insiders have traded $VERU stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $VERU stock by insiders over the last 6 months:
- MICHAEL L RANKOWITZ has made 2 purchases buying 150,000 shares for an estimated $84,350 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
VERU Hedge Fund Activity
We have seen 58 institutional investors add shares of VERU stock to their portfolio, and 35 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ADAGE CAPITAL PARTNERS GP, L.L.C. removed 5,561,111 shares (-70.7%) from their portfolio in Q4 2024, for an estimated $3,617,502
- MPM BIOIMPACT LLC added 4,285,365 shares (+inf%) to their portfolio in Q4 2024, for an estimated $2,787,629
- ROSALIND ADVISORS, INC. removed 2,694,503 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $1,752,774
- MILLENNIUM MANAGEMENT LLC removed 1,790,198 shares (-32.2%) from their portfolio in Q4 2024, for an estimated $1,164,523
- MORGAN STANLEY removed 1,550,534 shares (-51.4%) from their portfolio in Q4 2024, for an estimated $1,008,622
- EXOME ASSET MANAGEMENT LLC added 1,117,600 shares (+inf%) to their portfolio in Q4 2024, for an estimated $726,998
- PERCEPTIVE ADVISORS LLC removed 800,000 shares (-11.0%) from their portfolio in Q4 2024, for an estimated $520,400
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
